|Day Low/High||34.03 / 34.96|
|52 Wk Low/High||/|
Nuvelo soars after Bayer agrees to a partnership for its blood-clot dissolver.
Despite their risks, some of the best investing opportunities continue to be in low-priced stocks.
Jonathan Moreland is publisher of InsiderInsights.com, a Web site that analyzes insider trading. He writes a weekly column that appears on this page as part of his business relationship with TheStreet.com.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.